. "Appendix A: Chronology of Important Events Regarding Vaccine Safety." Immunization Safety Review: Multiple Immunizations and Immune Dysfunction. Washington, DC: The National Academies Press, 2002.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Immunization Safety Review: Multiple Immunizations and Immune Dysfunction
Year
Vaccine Licensure
Legislation and/or Policy Statements
IOM Reports on Vaccine Safety
2000
Pneumococcal vaccine for infants and young children licensed (Prevnar)
ACIP recommends pneumococcal vaccination for all children 2–23 months, and at-risk children 24–59 months (e.g., immunocompromised)
2001
October: ACIP drafts statement expressing a preference for use of thimerosal-free DtaP, Hib, and Hep B vaccines by March 2002
Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism
Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders
